Browsing by Author "Braña Garcia, Irene"
Now showing items 1-20 of 27
-
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy
Elez Fernandez, Mª Elena; Mulet Margalef, Núria; Sanso Martinez, Miriam; Mancuso, Francesco Mattia; Ros Montañá, Fco. Javier; Argilés Martinez, Guillem; Martini, Giulia; Sanz Garcia, Enrique; Baraibar Argota, Iosune; Salva Ballabrera, Francesc; Noguerido Castro, Alba; Cuadra-Urteaga, Jose Luis; Fasani, Roberta; Garcia Rodriguez, Ariadna; Jiménez Catalan, Juan José; Aguilar, Susana; Hernandez Losa, Javier; Braña Garcia, Irene; Nuciforo, Paolo Giovanni; Tabernero Caturla, Josep; Salazar, Ramón; Vivancos Prellezo, Ana; Landolfi, Stefania; Comas Navarro, Raquel; Ruiz Pace, Fiorella; Dienstmann, Rodrigo (MDPI, 2022-12-21) -
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study
Braña Garcia, Irene; Longhi, Alessandra; Awada, Ahmad; Subbiah, Vivek; Boni, Valentina; Delord, Jean-Pierre (American Association for Cancer Research, 2022-07-01) -
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers
Harding, James J.; Piha-Paul, Sarina; Shah, Ronak; Murphy, Jessica; Cleary, J. M.; Shapiro, G. I.; Braña Garcia, Irene (Springer Nature, 2023-02-06) -
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Vieito Villar, Maria; Sepúlveda, Juan Manuel; Galvao De Aquiar, Vladimir; Hernández-Guerrero, T.; Doger, B.; Saavedra Gadea, Omar; Carpio Segura, Cecilia Carmen; Braña Garcia, Irene; Moreno, Victor (Nature Portfolio, 2023-03-13) -
Confounding factors in the assessment of oral mucositis in head and neck cancer
Lorini, Luigi; Perri, Francesco; Vecchio, Stefania; Belgioia, Liliana; Vinches, Marie; Braña Garcia, Irene; Elad, Sharon; Bossi, Paolo (Springer, 2022-10) -
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
Lazar, Vladimir; Magidi, Shai; Girard, Nicolas; Savignoni, Alexia; Martini, Jean-François; Massimini, Giorgio; Braña Garcia, Irene; Tabernero Caturla, Josep; Felip Font, Enriqueta (Nature Research, 2021-04-28) -
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
Zandberg, Dan P.; Algazi, Alain P.; Jimeno, Antonio; Good, James S.; Fayette, Jérôme; Bouganim, Nathaniel; Braña Garcia, Irene (Elsevier, 2019-01) -
Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer: results from an expansion cohort of a phase I study
Olmedo García, María Eugenia; Forster, Martin; López-Criado, María Pilar; Braña Garcia, Irene; Flynn, Michael; Moreno, Victor (Springer, 2021-10) -
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Garralda Cabanas, Elena; Aguilar, Susana; Sala De Vedruna, Gemma; Viaplana Donato, Cristina; González-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Mancuso, Francesco Mattia; Fasani, Roberta; Jiménez Flores, José Antonio; Martinez, Paola; Oaknin Benzaquen, Ana Mazaltob; Antunes de Melo Oliveira, Ana Mafalda; Balmaña Gelpí, Judith; Carles Galceran, Joan; Macarulla Mercadé, Teresa; Elez Fernandez, Mª Elena; Alsina Maqueda, Maria; Braña Garcia, Irene; Felip Font, Enriqueta; Tabernero Caturla, Josep; Rodon Ahnert, Jordi; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Ramos Masdeu, Laia; Saura Manich, Cristina; Ruiz Pace, Fiorella; Dienstmann, Rodrigo (American Society of Clinical Oncology, 2020-05-14) -
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours
Ameratunga, Malaka; Braña Garcia, Irene; Bono, Petri; Postel-Vinay, Sophie; Plummer, Ruth; Aspegren, John (Springer Nature, 2020-12-08) -
ICO-ICS Praxi per al tractament mèdic i amb irradiació del càncer d'orofaringe, hipofaringe, laringe i nasofaringe
Basté Rotllan, Neus; Benavente Norza, Sergio; Braña Garcia, Irene; Cirauqui-Cirauqui, Beatriz; Felip Font, Enriqueta; Lozano-Borbalas, Alicia; Marruecos-Querol, Jordi; Mesia, Ricard; Miguelsanz-García, Santiago; Taberna Sanz, Miren; Vázquez-Fernández, Silvia; Rubió-Casadevall, Jordi (Institut Català de la SalutInstitut Català d'Oncologia, 2017-11) -
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice
Sabaté Gallego, Mònica; Pérez Esquirol, Eulalia; García Doladé, Núria; Vidal Guitart, Xavier; Farriols Danes, Anna Maria; Felip Font, Enriqueta; Braña Garcia, Irene; Carles Galceran, Joan; Morales Barrera, Rafael; Agustí Escasany, Maria Antònia; Carreras Soler, Maria Josep; Muñoz Couselo, Eva (Frontiers Media, 2022-08-22) -
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy
Pascual García, Mónica; Bonfill Teixidor, Ester; Planas Rigol, Ester; Rubio-Perez, Carlota; Iurlaro, Raffaella; Arias Piñeiro, Alexandra; Cuartas Maza, Ma Isabel; Sala Hojman, Ada; Escudero Monreal, Laura; Martínez Ricarte, Francisco Ramón; Huber Ruano, Isabel; Nuciforo, Paolo Giovanni; Braña Garcia, Irene; Garralda Cabanas, Elena; Vieito Villar, Maria; Espejo Ruiz, Carmen; Sahuquillo Barris, Joan; Tabernero Caturla, Josep; Seoane Suarez, Joan (Nature Research, 2019-06-11) -
Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study
Pistilli, Barbara; Braña Garcia, Irene; Shapiro, G. I.; Trigo, José Manuel; Boni, Valentina; Moreno, Victor (Elsevier, 2022-10) -
Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
Oaknin Benzaquen, Ana Mazaltob; Friedman, Claire F.; Roman, Lynda D.; D'Souza, Anishka; Braña Garcia, Irene; Bidard, François-Clement (Elsevier, 2020-10) -
New clinical trial designs in the era of Precision Medicine
Garralda Cabanas, Elena; Piris Giménez, Alejandro; Braña Garcia, Irene; Rodon Ahnert, Jordi; Tabernero Caturla, Josep; Dienstmann, Rodrigo (Wiley Open Access, 2019-01-30) -
Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies
Lorini, Luigi; Bescós Atin, Coro; Thavaraj, Selvam; Müller-Richter, Urs; Alberola Ferranti, Margarita; Pamias Romero, Jorge; Sáez Barba, Manuel; Braña Garcia, Irene; Nuciforo, Paolo Giovanni; Simonetti, Sara; De Pablo García-Cuenca, Alba (MDPI, 2021-08) -
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer
Rischin, Danny; Gil-Martin, Marta; González-Martin, Antonio; Braña Garcia, Irene; Hou, June Y.; Cho, Daniel (Elsevier, 2020-11-01) -
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
Rischin, Danny; Harrington, Kevin; Greil, Richard; Soulières, Denis; Tahara, Makoto; de Castro Junior, Gilberto; Braña Garcia, Irene (Elsevier, 2022-05) -
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
Burtness, Barbara; Rischin, Danny; Greil, Richard; Soulières, Denis; Tahara, Makoto; de Castro Junior, Gilberto; Braña Garcia, Irene; Basté Rotllan, Neus (American Society of Clinical Oncology, 2022-07-20)